SCHEMBL20208535

SCHEMBL20208535

CC(C)Cc1[nH]ncc1I

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
NOS1 P29475 1/20 0.31
CCNC P24863 1/20 0.30
CDK8 P49336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16882334 0.77 CBLB (0.33) TSHRCCNCCDK8
SCHEMBL12242610 0.73 TSHR (0.38) TSHRCCNCCDK8
SCHEMBL22863862 0.64 PDE2A (0.33)
SCHEMBL5323949 0.64 TSHR (0.36) TSHRCCNCCDK8
SCHEMBL1358702 0.62
SCHEMBL22561001 0.61 NOS2 (0.34)
SCHEMBL20627222 0.61 CHEK1 (0.39) NOS1CDK8
SCHEMBL14220944 0.60 KCNH2 (0.33)
SCHEMBL14417039 0.59 NPSR1 (0.35) TSHRNOS1
SCHEMBL13806855 0.58 GABRA1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096061-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2018098500-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. (US) 2018-05-31 WO disclosed